These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1636322)

  • 1. New perspectives for the chemotherapy and chemoprophylaxis of AIDS (acquired immune deficiency syndrome).
    De Clercq E
    Verh K Acad Geneeskd Belg; 1992; 54(1):57-88; discussion 88-9. PubMed ID: 1636322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy of human immunodeficiency virus (HIV) infection: anti-HIV agents targeted at early stages in the virus replicative cycle.
    De Clercq E
    Biomed Pharmacother; 1996; 50(5):207-15. PubMed ID: 8949401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New anti-HIV agents and targets.
    De Clercq E
    Med Res Rev; 2002 Nov; 22(6):531-65. PubMed ID: 12369088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of new potent and selective agents against HIV (human immunodeficiency virus).
    Pauwels R; Schols D
    Verh K Acad Geneeskd Belg; 1991; 53(6):629-55. PubMed ID: 1816706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antiviral agents that act in the early phases of the viral cycle].
    Damonte EB
    Rev Argent Microbiol; 1996; 28(4):204-16. PubMed ID: 9102661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perspectives for the chemotherapy of AIDS.
    De Clercq E
    Anticancer Res; 1987; 7(5B):1023-38. PubMed ID: 3324934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs.
    Witvrouw M; De Clercq E
    Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapeutic approaches to human immunodeficiency virus infections.
    Baba M
    Fukushima J Med Sci; 1992 Jun; 38(1):1-18. PubMed ID: 1284048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives.
    Pauwels R; Andries K; Desmyter J; Schols D; Kukla MJ; Breslin HJ; Raeymaeckers A; Van Gelder J; Woestenborghs R; Heykants J
    Nature; 1990 Feb; 343(6257):470-4. PubMed ID: 1689015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The present and future of AIDS chemotherapy].
    Stanková M
    Cas Lek Cesk; 1993 Jun; 132(11):321-8. PubMed ID: 8339310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current acquisitions in antiviral drugs (anti-HIV)].
    De Clercq E; Snoeck R
    J Pharm Belg; 1992; 47(4):317-22. PubMed ID: 1383488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of the acquired immune deficiency syndrome (AIDS): non-nucleoside inhibitors of the human immunodeficiency virus type 1 reverse transcriptase.
    De Clercq E
    Int J Immunopharmacol; 1991; 13 Suppl 1():83-9. PubMed ID: 1726686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of new enzyme inhibitors for the treatment of AIDS[ ].
    Herdewijn P
    Verh K Acad Geneeskd Belg; 1992; 54(2):139-53. PubMed ID: 1384252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of antiretroviral therapy for the acquired immunodeficiency syndrome and related disorders. A progress report.
    Yarchoan R; Broder S
    N Engl J Med; 1987 Feb; 316(9):557-64. PubMed ID: 3543683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New strategies for treating AIDS.
    Sandstrom PA; Folks TM
    Bioessays; 1996 May; 18(5):343-6. PubMed ID: 8639156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of integrase inhibitors for treatment of AIDS: an overview.
    Dubey S; Satyanarayana YD; Lavania H
    Eur J Med Chem; 2007 Sep; 42(9):1159-68. PubMed ID: 17367896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral therapy for human immunodeficiency virus infections.
    De Clercq E
    Clin Microbiol Rev; 1995 Apr; 8(2):200-39. PubMed ID: 7542558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Perspectives in AIDS chemotherapy].
    de Clercq E
    Cas Lek Cesk; 1989 Mar; 128(13):385-91. PubMed ID: 2571416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-dependent interference of a series of new 6-aminoquinolone derivatives with viral (HIV/CMV) transactivation.
    Stevens M; Balzarini J; Tabarrini O; Andrei G; Snoeck R; Cecchetti V; Fravolini A; De Clercq E; Pannecouque C
    J Antimicrob Chemother; 2005 Nov; 56(5):847-55. PubMed ID: 16150861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.